Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - SANGAMO THERAPEUTICS, INC | sgmo-ex321_8.htm |
| EX-31.2 - EX-31.2 - SANGAMO THERAPEUTICS, INC | sgmo-ex312_9.htm |
| EX-31.1 - EX-31.1 - SANGAMO THERAPEUTICS, INC | sgmo-ex311_10.htm |
| EX-23.1 - EX-23.1 - SANGAMO THERAPEUTICS, INC | sgmo-ex231_11.htm |
| EX-10.40 - EX-10.40 - SANGAMO THERAPEUTICS, INC | sgmo-ex1040_689.htm |
| EX-10.21 - EX-10.21 - SANGAMO THERAPEUTICS, INC | sgmo-ex1021_830.htm |
| EX-10.16 - EX-10.16 - SANGAMO THERAPEUTICS, INC | sgmo-ex1016_688.htm |
| EX-10.13 - EX-10.13 - SANGAMO THERAPEUTICS, INC | sgmo-ex1013_620.htm |
| EX-10.2 - EX-10.2 - SANGAMO THERAPEUTICS, INC | sgmo-ex102_368.htm |
| 10-K - 2017 10-K - SANGAMO THERAPEUTICS, INC | sgmo-10k_20171231.htm |
Exhibit 21.1
Subsidiaries of the Company
Gendaq Limited (U.K.)
Ceregene Inc. (Delaware)